Cardiovascular

Targeted Superior Vena Cava Isolation Combined With Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone Using Cryoballoon Ablation for Atrial Fibrillation.

TL;DR

Cryoballoon-based targeted SVC isolation guided by systematic mapping and provocation maneuvers significantly enhances freedom from atrial tachyarrhythmias without compromising safety.

Key Findings

SVC trigger detection rates increased significantly over the study period from 2020 to 2024.

  • Detection rates rose from 6.8% in 2020 to 21.3% in 2024.
  • The trend was statistically significant (P for trend = 0.023) as assessed by the Cochran-Armitage trend test.
  • The study included 990 consecutive patients who underwent cryoballoon ablation for AF between January 2020 and December 2024.
  • The increase in detection rates was attributed to systematic mapping and provocation maneuvers.

PVI combined with SVC isolation (SVCI) resulted in significantly higher 12-month freedom from atrial tachyarrhythmias compared to PVI alone.

  • 12-month freedom from atrial tachyarrhythmias was 90.9% in the PVI + SVCI group versus 76.4% in the PVI-only group (p = 0.037).
  • Comparison was made after 1:1 propensity score matching, yielding 55 matched pairs.
  • Redo ablation cases were excluded before matching.

Procedural time was modestly but significantly longer in the PVI + SVCI group compared to the PVI-only group.

  • Procedural time was 93 ± 26 min in the PVI + SVCI group versus 80 ± 20 min in the PVI-only group (p = 0.003).
  • The difference represents approximately 13 additional minutes for the combined procedure.

Fluoroscopy time and complication rates were comparable between the PVI + SVCI and PVI-only groups.

  • Fluoroscopy time was 12 ± 5 min in the PVI + SVCI group versus 10 ± 4 min in the PVI-only group (p = 0.276).
  • Complication rates were 5.5% in the PVI + SVCI group versus 3.6% in the PVI-only group (p = 0.500).
  • Both groups demonstrated low overall complication rates.
  • The non-significant differences indicate that adding SVCI did not meaningfully increase procedural risk.

The SVC is a common non-pulmonary vein trigger site in atrial fibrillation that is frequently underdetected without systematic mapping and provocation maneuvers.

  • The study was motivated by the observation that SVC triggers are frequently underdetected in routine practice.
  • A retrospective design was used, analyzing 990 consecutive patients over a 5-year period.
  • The increasing detection rates over time suggest that operator experience and systematic protocol use improve identification of SVC triggers.

What This Means

This research examined whether isolating an additional area of the heart called the superior vena cava (SVC) — in addition to the standard pulmonary vein isolation — improves outcomes for patients undergoing a procedure called cryoballoon ablation for atrial fibrillation (an irregular heart rhythm). The study looked at nearly 1,000 patients treated over five years and found that the rate at which doctors detected electrical triggers coming from the SVC increased substantially over time, from about 7% to 21%, likely because doctors became more systematic about looking for them. Among carefully matched patient groups, those who had both pulmonary vein isolation and SVC isolation were significantly more likely to remain free of abnormal heart rhythms at 12 months (91% vs. 76%). Importantly, adding the SVC isolation step only added about 13 minutes to the procedure and did not meaningfully increase radiation exposure or complication rates, both of which remained low in both groups. This suggests that the additional benefit came with minimal added risk. The findings highlight that SVC triggers are more common than previously recognized and that systematic efforts to find and treat them during ablation procedures may lead to better long-term outcomes for patients. This research suggests that routinely checking for and treating SVC triggers — using standardized mapping and stimulation techniques — during atrial fibrillation ablation procedures could improve the chances of patients staying free of arrhythmia recurrence over the following year. The results support incorporating this approach into clinical practice, though the retrospective and single-center nature of the study means further prospective research would help confirm these findings.

Have a question about this study?

Citation

Han Y, Bao Y, Xie Y, Wei Y, Luo Q, Ling T, et al.. (2026). Targeted Superior Vena Cava Isolation Combined With Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone Using Cryoballoon Ablation for Atrial Fibrillation.. Clinical cardiology. https://doi.org/10.1002/clc.70469